QIAGEN N.V. (Nasdaq: QGEN) announced the successful completion of the conditional, voluntary public tender offer for the shares in Exiqon A/S, a world leader in RNA technology. The extended Offer Period expired yesterday, on 22 June 2016, at 23.59 (CET).
{iframe}http://www.streetinsider.com/Corporate+News/Qiagen+(QGEN)+Completes+Exiqon+Tender+Offer/11766535.html{/iframe}